US FDA sends SOS to Indian drugmakers for critical cancer medicine amid US shortage

The U.S. FDA is trying to secure supplies of ifosfamide, a cancer treatment that is in short supply due to production disruptions. IDMA is gathering information on potential Indian suppliers to address the ongoing drug shortage in the United States.